ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

MRK Merck and Co Inc

125,40
0,17 (0,14%)
20 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Merck and Co Inc MRK NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
0,17 0,14% 125,40 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
125,71 124,89 126,12 125,78 125,23
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
19.4.202413:04PRNCASanté Canada approuve KEYTRUDA® comme traitement de première..
10.4.202413:13IHMARKETNEWSDelta Generates US$37 Million Profit in Q1, Google and Intel..
04.4.202412:45BWMerck Initiates Phase 3 Clinical Trial of MK-1084, an..
03.4.202414:00BWREJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan..
01.4.202412:45BWMerck to Hold First-Quarter 2024 Sales and Earnings..
28.3.202411:45BWEuropean Commission Approves Merck’s KEYTRUDA®..
27.3.202411:54IHMARKETNEWSGameStop Shares Tumble 20% in Pre-Market Trading Amid..
26.3.202423:21BWFDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a..
21.3.202411:45BWMerck Provides Update on Phase 3 KEYLYNK-006 Trial..
19.3.202414:00BWMerck Announces Positive Data on V116, an Investigational,..
15.3.202421:23PRNUSFarmSee Ltd Announces the Completion of a Minority..
15.3.202411:45BWMerck’s KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy..
13.3.202408:00BWMerck Announces Plans to Conduct Clinical Trials of a Novel..
11.3.202413:15BWMerck Completes Acquisition of Harpoon Therapeutics, Inc.
06.3.202416:25BWGilead and Merck Announce Phase 2 Data Showing an..
05.3.202415:03IHMARKETNEWSFutures Pointing To Continued Weakness On Wall Street
05.3.202412:45BWMerck to Participate in the Barclays 26th Annual Global..
04.3.202412:45BWMerck to Participate in the Leerink Partners Global..
27.2.202412:45BWMerck to Participate in the TD Cowen 44th Annual Health Care..
23.2.202412:20BWMerck Receives Positive EU CHMP Opinion for KEYTRUDA®..
20.2.202422:14EDGAR2Form 8-K - Current report
20.2.202412:45BWFDA Grants Priority Review to Merck's Application for..
15.2.202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202422:40EDGAR2Form 144 - Report of proposed sale of securities
14.2.202422:30EDGAR2Form 144 - Report of proposed sale of securities
14.2.202422:24EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:50EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:48EDGAR2Form 144 - Report of proposed sale of securities
12.2.202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202413:05PRNCAHealth Canada Approves KEYTRUDA® in combination with..
09.2.202422:06EDGAR2Form 144 - Report of proposed sale of securities
08.2.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202413:00PRNCAMERCK CANADA ANNONCE UNE COLLABORATION AVEC L'INSTITUT..
07.2.202422:09EDGAR2Form 144 - Report of proposed sale of securities
05.2.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202412:33PRNUSElanco Announces Sale of Aqua Business for $1.3 Billion
02.2.202422:35EDGAR2Form 144 - Report of proposed sale of securities
02.2.202422:09EDGAR2Form 144 - Report of proposed sale of securities
02.2.202422:08EDGAR2Form 144 - Report of proposed sale of securities
02.2.202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202412:39EDGAR2Form 8-K - Current report
01.2.202412:30BWMerck Announces Fourth-Quarter and Full-Year 2023 Financial..
27.1.202416:00BWMerck’s KEYTRUDA® (pembrolizumab) Reduced the Risk of Death..
26.1.202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26.1.202416:00BWMerck’s KEYTRUDA® (pembrolizumab) Significantly Improved..
25.1.202414:07DJNLava Therapeutics Shares Rise as Drug Set for Test With..
24.1.202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock